Literature DB >> 2184752

Insulin receptor structure and function in normal and pathological conditions.

A B Becker1, R A Roth.   

Abstract

The insulin receptor is a large cell surface glycoprotein that concentrates insulin at the site of action and also initiates responses to insulin. The receptor is a disulfide-linked oligomer comprised of two alpha and two beta subunits. Signal transduction through the insulin receptor appears to require the activation of an intrinsic tyrosine-specific protein kinase activity. A variety of disorders, both acquired and genetic, are associated with the development of insulin resistance and are frequently the result of cellular defects in insulin receptor structure, function, and action. The recent cloning of several mutant receptors from patients with genetic forms of extreme insulin resistance has increased our understanding of insulin resistance on the molecular level.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2184752     DOI: 10.1146/annurev.me.41.020190.000531

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  5 in total

1.  Recombinant human insulin-like growth factor I (rhIGF I) reduces hyperglycaemia in patients with extreme insulin resistance.

Authors:  E J Schoenle; P D Zenobi; T Torresani; E A Werder; M Zachmann; E R Froesch
Journal:  Diabetologia       Date:  1991-09       Impact factor: 10.122

Review 2.  Thiazolidinediones: effects on insulin resistance and the cardiovascular system.

Authors:  C E Quinn; P K Hamilton; C J Lockhart; G E McVeigh
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

3.  Elevated protein tyrosine phosphatase activity and increased membrane viscosity are associated with impaired activation of the insulin receptor kinase in old rats.

Authors:  O Nadiv; M Shinitzky; H Manu; D Hecht; C T Roberts; D LeRoith; Y Zick
Journal:  Biochem J       Date:  1994-03-01       Impact factor: 3.857

Review 4.  β-Adrenergic Receptor and Insulin Resistance in the Heart.

Authors:  Supachoke Mangmool; Tananat Denkaew; Warisara Parichatikanond; Hitoshi Kurose
Journal:  Biomol Ther (Seoul)       Date:  2017-01-01       Impact factor: 4.634

5.  A complex of GRB2-dynamin binds to tyrosine-phosphorylated insulin receptor substrate-1 after insulin treatment.

Authors:  A Ando; K Yonezawa; I Gout; T Nakata; H Ueda; K Hara; Y Kitamura; Y Noda; T Takenawa; N Hirokawa
Journal:  EMBO J       Date:  1994-07-01       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.